Skip to Main content Skip to Navigation
Journal articles

Role of Toll-like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome

Ygal Benhamou 1, 2, 3 Jeremy Bellien 2 Guillaume Armengol 4 Ebba Brakenhielm 2 Sahil Adriouch 5 Michele Iacob 2 Isabelle Remy-Jouet 2 Véronique Le Cam-Duchez 2 Christelle Monteil 6 Sylvanie Renet 2 Fabienne Jouen 5 Laurent Drouot 5 Jean-François Ménard 7 Jeanne-Yvonne Borg 8 Christian Thuillez 9 Olivier Boyer 5 Hervé Levesque 1 Vincent Richard 10 Robinson Joannides 2, 3
1 Service de Médecine Interne [CHU Rouen]
2 EnVI - Endothélium, valvulopathies et insuffisance cardiaque
3 CIC Rouen - Centre d'Investigation Clinique [CHU Rouen]
4 UNIROUEN UFR Santé - UNIROUEN - UFR Santé
5 Physiopathologie et biothérapies des maladies inflammatoires et autoimmunes
6 EnVI - Nouvelles Cibles Pharmacologiques de la Protection Endothéliale et de l'Insuffisance Cardiaque
7 LITIS - Laboratoire d'Informatique, de Traitement de l'Information et des Systèmes
8 Laboratoire d'hématologie [Rouen]
9 Pharmacologie des Dysfonctionnements Endotheliaux et Myocardiques
10 Institut Pasteur de Dakar
Abstract : Objective. To assess the role of Toll-like receptors (TLRs) in antiphospholipid antibody (aPL)-mediated vascular abnormalities in patients with primary arterial antiphospholipid syndrome (APS). Methods. Forty-eight subjects participated in the study. Arterial function and structure and TLR pathway activation were determined in patients with primary arterial APS and matched controls. The pathogenic effects of aPL isolated from patients were assessed in wild-type (WT) and TLR-knockout mice. Results. APS patients had endothelial dysfunc-tion, arterial stiffening, and hypertrophy, as evidenced by decreased brachial artery endothelium-dependent flow-mediated dilation (FMD) and increased aortic pulse wave velocity and carotid intima-media thickness (IMT), as compared with controls. Plasma samples from APS patients revealed decreased nitric oxide (NO) availability and a pro-oxidative, proinflammatory, and prothrombotic state illustrated by a decrease in nitrite and an increase in lipid peroxidation, tumor necrosis factor ␣ levels, and tissue factor (TF) levels. Furthermore , TLR pathway activation was found in APS patients with increased TLR-2 and TLR-4 messenger RNA expression and increased protein levels of the activated TLR transduction protein interleukin-1 receptor-associated kinase 1 in peripheral blood mononuclear cells. Moreover, agonist-stimulated cell-surface expression of TLR-2 and TLR-4 in circulating monocytes was higher in APS patients than in controls. These changes were positively associated with IMT and negatively associated with FMD. Finally, aPL injection decreased mesenteric endothelium-dependent relaxation and increased TF expression in WT mice but not in TLR-2-or TLR-4-knockout mice. Conclusion. This translational study supports the notion that TLR-2 and TLR-4 play a role in mediating vascular abnormalities in patients with primary arterial APS. TLRs thus constitute a promising pharmacologic target for preventing cardiovascular complications in APS.
Document type :
Journal articles
Complete list of metadatas

Cited literature [51 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02296566
Contributor : Ebba Brakenhielm <>
Submitted on : Wednesday, September 25, 2019 - 12:06:46 PM
Last modification on : Wednesday, April 1, 2020 - 12:14:03 PM
Long-term archiving on: : Sunday, February 9, 2020 - 5:45:35 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

RIIP | RIIP_DAKAR | LITIS | COMUE-NORMANDIE | INSA-ROUEN | UNIROUEN | UNILEHAVRE | INSA-GROUPE | U1234PANTHER

Citation

Ygal Benhamou, Jeremy Bellien, Guillaume Armengol, Ebba Brakenhielm, Sahil Adriouch, et al.. Role of Toll-like Receptors 2 and 4 in Mediating Endothelial Dysfunction and Arterial Remodeling in Primary Arterial Antiphospholipid Syndrome. Arthritis & rheumatology, Wiley, 2014, 66 (11), pp.3210-3220. ⟨10.1002/art.38785⟩. ⟨inserm-02296566⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

140